CRADA

Newly Rebranded Inteliquet Bolstering Precision Oncology Offerings Through NCI Contract
Premium

The company formerly known as TransMed Systems looks to bring "clarity and transparency" to the emerging field of precision oncology and in patient-trial matching.

Breaking News

BioNexus Gene Lab, Shenzhen Rongguang Team up on Cancer Screening, Precision Medicine Programs
Population Testing for BRCA1/2 Appears Cost-Effective in Younger Canadian Women
Octernal Stopping Clinical Testing, Reducing Workforce After Safety, Efficacy Issues in Two Trials
NKGen Biotech Doses First Patient in Phase II Portion of Alzheimer's Cell Therapy Trial
Massive Bio, Foundation Medicine Partner to Improve Oncology Clinical Trial Enrollment
In Brief This Week: Sophia Genetics, Cartesian, NS Pharma, Allarity, Cabrini Health

CRADA

Newly Rebranded Inteliquet Bolstering Precision Oncology Offerings Through NCI Contract Premium

BioNexus Gene Lab, Shenzhen Rongguang Team up on Cancer Screening, Precision Medicine Programs

Population Testing for BRCA1/2 Appears Cost-Effective in Younger Canadian Women

Octernal Stopping Clinical Testing, Reducing Workforce After Safety, Efficacy Issues in Two Trials

NKGen Biotech Doses First Patient in Phase II Portion of Alzheimer's Cell Therapy Trial

Massive Bio, Foundation Medicine Partner to Improve Oncology Clinical Trial Enrollment

In Brief This Week: Sophia Genetics, Cartesian, NS Pharma, Allarity, Cabrini Health

Newly Rebranded Inteliquet Bolstering Precision Oncology Offerings Through NCI Contract
Premium